Abstract
Bipolar disorder is a chronic mood disorder defined by recurrent episodes of mania or hypomania alternating with depression, separated by intervals of relative remission termed euthymia. Affecting roughly 1 to 2 percent of the population across the full spectrum, it is indexed by the Medical Subject Headings vocabulary under the mood disorders. Its interest for cognitive psychology lies less in the dramatic mood swings than in a quieter finding: measurable deficits in attention, verbal memory, and executive function persist even during euthymia, marking the disorder as a disturbance of cognition and not of affect alone. This article sets out the diagnostic spectrum, the cognitive profile across mood states, the genetic and neuroimaging evidence, the circadian and social-rhythm disruption that times relapse, and treatment. Three interactive demonstrations model the mood spectrum, social rhythms, and the Young Mania Rating Scale.
Keywords: mania, hypomania, euthymia, cognitive impairment, social rhythms
Bipolar disorder is distinguished from ordinary variation in mood by the severity, duration, and consequence of its episodes. A manic episode is not high spirits but a sustained, qualitatively abnormal state of elevated or irritable mood with increased energy, reduced need for sleep, racing thoughts, and impaired judgment, lasting at least a week and often requiring hospitalization (Grande et al., 2016). The depressive pole is a full major depressive episode, and it is where people with the disorder spend most of their symptomatic time. The alternation between the two, across years, is the defining course.
What makes the disorder a case for cognitive psychology rather than affective science alone is the discovery that its cognitive costs do not lift when mood recovers. Neuropsychological studies find that patients in euthymia — no longer manic, no longer depressed — still perform below matched controls on tests of sustained attention, verbal learning and memory, and executive control (Martinez-Aran et al., 2004; Bourne et al., 2013). The mood episodes are the visible surface; the persistent cognitive deficit is the trait that underlies much of the disorder's disability.
Key Takeaways
- Bipolar disorder is defined by episodes of mania or hypomania alternating with depression; the type is set by whether a full manic episode has ever occurred (bipolar I) or only hypomania with major depression (bipolar II).
- Cognitive deficits in attention, verbal memory, and executive function persist into euthymia, making the disorder a trait-level disturbance of cognition, not only a state-level disturbance of mood.
- Twin and molecular studies place its heritability among the highest in psychiatry, and the genetic architecture is highly polygenic, overlapping with schizophrenia and major depression.
- Disruption of circadian and social rhythms can precipitate episodes, and rhythm-regularizing therapy is an evidence-based adjunct to mood-stabilizing medication.
- The Young Mania Rating Scale scores manic severity across eleven items for a total of 0–60 and is the standard outcome measure in mania trials.
What Bipolar Disorder Is
Bipolar disorder is a recurrent mood disorder in which episodes of pathologically elevated mood — mania or its milder form hypomania — occur, usually interleaved with episodes of major depression. A manic episode is a distinct period of abnormally elevated, expansive, or irritable mood accompanied by increased goal-directed activity or energy, lasting at least one week (or any duration if hospitalization is required), and severe enough to cause marked impairment, psychotic features, or the need for admission. Hypomania is the same symptom picture in attenuated form: shorter, less severe, and without the psychosis or gross functional collapse that marks full mania. The depressive episodes meet the standard criteria for major depression.
Cross-national epidemiology places the lifetime prevalence of bipolar I disorder near 0.6% and of the full bipolar spectrum near 2.4%, with strikingly consistent rates across countries and a close association with anxiety and substance-use comorbidity (Merikangas et al., 2011). The disorder is chronic and episodic. Between episodes many patients return to euthymia — a mood state within the normal range — but the return is often incomplete, and residual symptoms and cognitive deficits are common. Untreated, episodes tend to recur, and an influential clinical observation is that they may become more frequent and more easily triggered over time, a pattern that motivated the kindling model of the illness course (Post, 1992). The Medical Subject Headings vocabulary indexes the condition under mood disorders and, historically, under the older rubric of manic-depressive illness, the term used in the field's definitive reference text (Goodwin & Jamison, 2007).
Figure 1
The Bipolar Mood Spectrum Over Time
The Diagnostic Spectrum
Bipolar disorder is not a single presentation but a spectrum, distinguished chiefly by the severity of the elevated pole. The distinction matters clinically because it predicts course, treatment response, and risk, and it matters conceptually because it shows the diagnostic boundary being drawn on the manic side rather than the depressive one.
| Presentation | Defining feature |
|---|---|
| Bipolar I disorder | At least one full manic episode, with or without a history of major depression; the manic episode alone establishes the diagnosis. |
| Bipolar II disorder | At least one hypomanic episode and at least one major depressive episode, with no history of full mania; not a milder illness, given the depressive burden. |
| Cyclothymic disorder | Chronic, fluctuating subthreshold hypomanic and depressive symptoms lasting at least two years, never meeting the threshold for a full episode. |
The spectrum framing also captures the everyday clinical difficulty that most people who eventually receive a bipolar diagnosis first present in a depressive episode, indistinguishable at that moment from unipolar depression. The bipolarity is revealed only when a manic or hypomanic episode later appears, which is why the elevated pole is diagnostically decisive: it is the feature that, once observed, reclassifies the entire course.
The mood spectrum and the diagnostic threshold
Raise or lower the two poles. The diagnosis turns on the elevated side: a peak that clears the mania line makes it bipolar I; a peak that reaches only hypomania, paired with a full depressive trough, makes it bipolar II.
Current pattern: Bipolar II. The depressive pole is at full major-depression depth, and the elevated pole reaches hypomania only.
Schematic. Episode timing is fixed; only the amplitude of each pole is under your control, to isolate the role of the elevated pole in classification.
Cognitive Function Across Mood States
The cognitive profile of bipolar disorder is the feature that most directly concerns cognitive psychology, and its central finding is counterintuitive. During acute episodes, cognition is impaired in the expected way — attention and memory suffer in depression, and judgment, distractibility, and inhibitory control collapse in mania. The surprise is what remains during euthymia. In a landmark comparison of patients in manic or hypomanic, depressed, and euthymic states against healthy controls, deficits in verbal memory and executive function were present in every group, including the euthymic one, indicating that impairment is not merely a byproduct of disturbed mood (Martinez-Aran et al., 2004).
An individual-patient-data meta-analysis of neuropsychological testing in euthymic bipolar disorder confirmed and quantified the pattern: robust, medium-to-large deficits across attention, processing speed, verbal memory, and executive measures, stable across studies and not attributable to residual mood symptoms or medication alone (Bourne et al., 2013). Verbal memory in particular tracks functional outcome — how well a patient works and lives between episodes — more closely than symptom counts do. This reframes the disorder: the mood episodes are acute and visible, but a substantial part of the long-term disability is carried by a persistent, trait-like cognitive deficit that the older, mood-centered picture missed entirely.
Neurobiology
Bipolar disorder is among the most heritable of psychiatric conditions. Twin studies estimate heritability at roughly 60–85%, and molecular work has shown the genetic architecture to be highly polygenic — many common variants of small effect, with substantial genetic correlation to schizophrenia and to major depression, blurring the old categorical boundaries between them (Craddock & Sklar, 2013). No single gene accounts for meaningful risk; the inherited liability is distributed across the genome and shared, in part, across diagnoses.
Neuroimaging locates the disorder in the circuits that regulate emotion. A critical appraisal of the imaging literature proposed that bipolar disorder reflects abnormalities in the neural systems supporting emotion regulation — reduced prefrontal modulation of limbic structures such as the amygdala, yielding a failure of top-down control over emotional responses (Phillips & Swartz, 2014). Converging work on the emerging neurobiology implicates disturbances in mitochondrial function, ion-channel regulation, and circadian and intracellular signaling, connecting the molecular genetics to the cellular processes plausibly underlying mood instability (Harrison et al., 2018). The kindling and behavioral-sensitization model offers a complementary account at the level of course rather than mechanism: early episodes are often precipitated by psychosocial stressors, but with each recurrence the threshold for the next falls, so that later episodes arise more autonomously — a progressive sensitization of the underlying neural substrate (Post, 1992).
Young Mania Rating Scale (YMRS)
Eleven items: seven scored 0–4 and four weighted items scored 0–8, for a total of 0–60. The wider range on the four harder-to-rate items gives the clinician more gradations. Defaults reproduce the case in the Worked Example.
Total YMRS: 33 / 60 — severe mania.
The YMRS is a severity measure, not a diagnostic test; thresholds shown are conventional trial cut-offs, not formal diagnostic criteria.
Circadian and Social Rhythms
One of the more distinctive features of bipolar disorder is its tie to biological and social rhythms. Sleep loss is among the most reliable precipitants of mania, and disruption of the daily schedule — a time-zone change, a new work shift, a night without sleep — can tip a vulnerable person into an episode. The social zeitgeber hypothesis formalizes this: social cues such as mealtimes, work, and social contact entrain the body's circadian rhythms, and life events that disrupt those social cues destabilize the underlying biological clock, precipitating mood episodes in people predisposed to them.
This mechanistic idea became a treatment. Interpersonal and social rhythm therapy (IPSRT) helps patients regularize their daily routines — consistent sleep, wake, meal, and activity times — while addressing the interpersonal problems that disrupt them. In a two-year controlled trial, patients assigned to IPSRT during the acute phase took longer to relapse and had more stable rhythms than those given intensive clinical management, establishing rhythm regularity as a genuine protective factor and not merely a marker of wellness (Frank et al., 2005). The demonstration below lets a reader manipulate the regularity of daily routines and watch its modeled effect on mood stability.
Social rhythms and modeled mood stability
The social zeitgeber hypothesis holds that regular daily cues entrain the biological clock. Increase routine regularity and sleep protection to raise modeled stability — the mechanism interpersonal and social rhythm therapy targets.
Modeled stability: 50 / 100 — moderate modeled relapse pressure.
Illustrative monotone model, not a clinical predictor. Sleep is weighted slightly higher because sleep loss is among the most reliable precipitants of mania.
Measurement and Assessment
The standard instrument for rating manic severity is the Young Mania Rating Scale (YMRS), a clinician-administered interview of eleven items covering elevated mood, increased activity and energy, sexual interest, sleep, irritability, speech, language and thought disorder, thought content, disruptive or aggressive behavior, appearance, and insight (Young et al., 1978). Seven items are scored 0–4 and four items — irritability, speech, thought content, and disruptive behavior — are scored 0–8, because they are harder to rate reliably and the wider range gives the clinician more gradations; the total ranges from 0 to 60. As with any well-designed severity scale, the score is largely independent of the specific symptom content: two patients with different manic presentations but equal overall severity receive comparable totals, which is what allows the YMRS to serve as the primary outcome measure across heterogeneous mania trials. The demonstration above reproduces the scoring, and the Worked Example computes a case total.
Table 1
Table 1
Principal Treatments for Bipolar Disorder
| Treatment | Role | Evidence |
|---|---|---|
| Lithium | Mood stabilizer; acute mania and long-term relapse prevention; reduces suicide risk | First-line maintenance; the best-established anti-suicidal agent in psychiatry |
| Anticonvulsants (valproate, lamotrigine) | Mood stabilization; lamotrigine favors the depressive pole | First-line alternatives or adjuncts to lithium |
| Atypical antipsychotics | Acute mania, and several are effective in bipolar depression and maintenance | First-line for acute mania; increasingly used across phases |
| Psychoeducation and rhythm therapy | Relapse prevention; IPSRT regularizes social and circadian rhythms | Evidence-based adjuncts that lengthen time to relapse |
Note. Antidepressants are used cautiously and rarely as monotherapy, given the risk of precipitating mania or rapid cycling; contemporary guidelines emphasize combined pharmacological and psychosocial management (Geddes & Miklowitz, 2013; McIntyre et al., 2020).
Worked Example
Consider a patient assessed on the Young Mania Rating Scale during an acute episode. The clinician rates all eleven items — seven on a 0–4 scale and four (irritability, speech, thought content, and disruptive behavior) on a 0–8 scale.
Suppose the seven 0–4 items — elevated mood, increased activity, sexual interest, sleep, language–thought disorder, appearance, and insight — are rated 3, 3, 2, 3, 2, 1, and 3. Their subtotal is:
3 + 3 + 2 + 3 + 2 + 1 + 3 = 17
Suppose the four 0–8 items — irritability, speech, thought content, and disruptive behavior — are rated 4, 6, 4, and 2. Their subtotal is:
4 + 6 + 4 + 2 = 16
The YMRS total is the sum of the two:
17 + 16 = 33
A total of 33, out of a maximum of 60, indicates a clearly manic state well above the threshold conventionally used to define clinically significant mania (a score of about 12 or higher is a common cutoff for entry into mania trials, and roughly 20 or higher marks moderate-to-severe mania). Re-rating the same eleven items after treatment is how response is quantified; the weighting of the four difficult-to-rate items on the wider 0–8 scale means that changes in irritability, pressured speech, grandiose or paranoid content, and disruptive behavior move the total more than changes in the seven ordinary items — by design, because those four best track the severity of an acute manic state.
Discussion
The most consequential shift in how bipolar disorder is understood is the move from a purely affective model to one that treats cognition as central. For most of the disorder's history, the mood episodes were the whole of the illness, and the intervals between them were assumed to be periods of full recovery. The neuropsychological evidence overturned the second assumption: euthymia is not the absence of the disorder but a state in which mood has normalized while cognition has not (Bourne et al., 2013). This matters because it relocates a large share of the long-term disability from the acute episode to the persistent deficit, and it reframes treatment goals to include cognition and function, not symptom remission alone.
The disorder also illustrates how a mechanistic hypothesis can become a therapy. The social zeitgeber account began as an explanation for why life events precipitate episodes and became, through IPSRT, an intervention that regularizing rhythms measurably delays relapse (Frank et al., 2005). And the genetics have forced a reconsideration of diagnostic boundaries: the substantial shared heritability with schizophrenia and major depression suggests that the categorical distinctions inherited from twentieth-century nosology cut across a more continuous underlying liability than the diagnostic manuals imply (Craddock & Sklar, 2013).
Cognitive Implications
Bipolar disorder earns its place in cognitive psychology because it dissociates mood from cognition in a way few conditions do. If cognitive impairment were simply a consequence of being depressed or manic, it would resolve when mood resolves. It does not — which means the disorder carries a cognitive deficit that is partly independent of mood state and behaves like a trait (Martinez-Aran et al., 2004). The affected domains are the familiar machinery of cognitive psychology: sustained and selective attention, the encoding and retrieval of verbal material, processing speed, and the executive functions of working memory, planning, and inhibitory control.
That profile has a practical corollary that theory alone would not predict: verbal memory and executive performance in euthymia forecast real-world functioning better than mood-symptom severity does (Bourne et al., 2013). A patient can be symptomatically well — neither manic nor depressed — and still be functionally impaired by a cognitive deficit the mood-based diagnosis does not capture. The lesson for cognitive science is that a disorder defined by its emotional extremes turns out to be, in substantial part, a disorder of the cognitive systems that operate in the calm between them.
Current Directions
Contemporary research is pursuing several fronts at once. The first is staging and early intervention: the kindling-derived idea that the illness progresses motivates efforts to intervene before recurrent episodes entrench the course, and to treat cognition as a target in its own right rather than a downstream symptom (Vieta et al., 2018). The second is the neurobiological program that seeks to convert the polygenic and imaging findings into mechanism — pursuing mitochondrial, ion-channel, and circadian signaling pathways as candidate substrates and as potential drug targets beyond the century-old mainstay of lithium (Harrison et al., 2018). The third is the effort to integrate the disorder's cognitive, circuit-level, and clinical descriptions into a single account that can guide personalized treatment across the long, fluctuating course of the illness (Grande et al., 2016; McIntyre et al., 2020). Across all three, the through-line is the same reframing this article has traced: bipolar disorder as a chronic, progressive, and fundamentally cognitive condition, not an episodic disturbance of mood alone.
Common Misconceptions
- Bipolar disorder just means rapid, unpredictable mood swings.
- The disorder is defined by sustained episodes of mania, hypomania, and depression lasting days to weeks, not by moment-to-moment shifts in mood (Grande et al., 2016). The colloquial use of the word bipolar to mean mercurial temperament misrepresents a condition whose episodes are prolonged and qualitatively distinct states.
- Between episodes, people with bipolar disorder are completely well.
- Deficits in attention, verbal memory, and executive function persist during euthymia, and residual symptoms are common; recovery of mood is not the same as recovery of cognition (Bourne et al., 2013). Much of the disorder's long-term disability lies in this inter-episode period.
- Mania is simply feeling very happy or productive.
- A manic episode is a pathological state that can involve irritability, agitation, psychosis, dangerous impulsivity, and profound impairment of judgment, frequently requiring hospitalization (Young et al., 1978). It is destructive, not merely euphoric, and the elevated mood is often experienced as distressing rather than pleasant.
Glossary
- Amygdala.
- A limbic structure central to emotional processing whose reduced regulation by prefrontal cortex is implicated in the emotion-dysregulation model of bipolar disorder.
- Bipolar I disorder.
- The form defined by at least one full manic episode, with or without a history of major depression.
- Bipolar II disorder.
- The form defined by at least one hypomanic episode and at least one major depressive episode, with no history of full mania.
- Cyclothymic disorder.
- Chronic, fluctuating subthreshold hypomanic and depressive symptoms persisting at least two years without ever meeting the threshold for a full episode.
- Euthymia.
- A mood state within the normal range between episodes; in bipolar disorder it is frequently accompanied by residual cognitive deficits.
- Executive function.
- The set of control processes — working memory, planning, inhibition, flexibility — that are impaired in bipolar disorder across mood states.
- Hypomania.
- A milder, shorter form of mania without psychosis or the gross functional impairment of a full manic episode; the defining elevated state of bipolar II disorder.
- Interpersonal and social rhythm therapy.
- A manualized psychosocial treatment that stabilizes daily routines and sleep-wake timing to protect the biological clock and lengthen time to relapse when added to medication.
- Kindling.
- Post's model of illness course in which each successive episode lowers the threshold for the next, so that recurrences become more frequent and more autonomous over time.
- Lithium.
- The prototypical mood stabilizer, first-line for maintenance treatment and uniquely associated with a reduction in suicide risk among bipolar patients.
- Mania.
- A distinct period of abnormally elevated, expansive, or irritable mood with increased energy, lasting at least a week and causing marked impairment; its occurrence defines bipolar I disorder.
- Mood stabilizer.
- A medication such as lithium or an anticonvulsant that treats acute episodes and prevents relapse without preferentially inducing the opposite mood pole.
- Social zeitgeber hypothesis.
- The proposal that social cues entrain circadian rhythms and that life events disrupting those cues destabilize the biological clock, precipitating mood episodes.
- Young Mania Rating Scale.
- The standard clinician-rated instrument scoring manic severity 0–60 across eleven items, with four difficult-to-rate items weighted on a wider scale.
Key Researchers
Ellen Frank
(living). Professor emerita of psychiatry at the University of Pittsburgh; developed interpersonal and social rhythm therapy and the social zeitgeber account of episode timing. Wikipedia - Faculty Page
Frederick K. Goodwin
(1936–2020). Was a psychiatrist and former director of the National Institute of Mental Health; co-author of Manic-Depressive Illness, the field's standard reference. Wikipedia - Wikidata
Kay Redfield Jamison
(living). Professor of Psychiatry at the Johns Hopkins University School of Medicine; co-author of the definitive reference text on manic-depressive illness and an influential writer on the disorder. Wikipedia - Faculty Page
Emil Kraepelin
(1856–1926). Was a German psychiatrist whose nosology first separated manic-depressive illness from dementia praecox, establishing the diagnostic category from which the modern concept of bipolar disorder descends. Wikipedia - Wikidata
David J. Miklowitz
(living). Professor of psychiatry at the University of California, Los Angeles; developed family-focused therapy and helped establish the evidence base for psychosocial treatment in bipolar disorder. ORCID - Google Scholar
Eduard Vieta
(living). Professor of psychiatry at the University of Barcelona; a leading contemporary researcher on the staging, cognition, and treatment of bipolar disorder. ORCID - Wikipedia
Frequently Asked Questions
What is the difference between bipolar I and bipolar II disorder?
Bipolar I is defined by at least one full manic episode, which alone establishes the diagnosis, whereas bipolar II requires at least one hypomanic episode together with a major depressive episode and no history of full mania (Grande et al., 2016). Bipolar II is not simply a milder illness, because its depressive burden can be severe.
Is bipolar disorder the same as having mood swings?
No; the disorder is defined by sustained episodes of mania, hypomania, or depression lasting days to weeks, not by the rapid, moment-to-moment mood shifts the phrase usually describes (Young et al., 1978). The episodes are prolonged, qualitatively abnormal states.
Do cognitive problems in bipolar disorder go away between episodes?
Deficits in attention, verbal memory, and executive function persist during euthymia, when mood has returned to normal, and they predict long-term functioning (Martinez-Aran et al., 2004; Bourne et al., 2013). Recovery of mood does not guarantee recovery of cognition.
Is bipolar disorder inherited?
It is among the most heritable psychiatric conditions, with twin-study heritability estimated at roughly 60 to 85 percent, but the genetic architecture is highly polygenic and overlaps with schizophrenia and major depression (Craddock & Sklar, 2013). No single gene determines risk.
Why does sleep loss trigger mania?
Disruption of circadian and social rhythms destabilizes the biological clock, and sleep loss is among the most reliable precipitants of a manic episode in susceptible people (Frank et al., 2005). This is the basis of the social zeitgeber hypothesis and of rhythm-regularizing therapy.
How is the severity of mania measured?
The Young Mania Rating Scale rates eleven items for a total of 0 to 60, with four difficult-to-rate items weighted on a wider 0 to 8 scale (Young et al., 1978). It is the standard outcome measure in trials of treatments for mania.
What medications treat bipolar disorder?
Lithium, certain anticonvulsants such as valproate and lamotrigine, and several atypical antipsychotics are the mainstays, chosen by illness phase; lithium remains first-line for maintenance and uniquely reduces suicide risk (Geddes & Miklowitz, 2013). Antidepressants are used cautiously because they can precipitate mania.
Can psychotherapy help in bipolar disorder?
Yes; evidence-based psychosocial treatments such as interpersonal and social rhythm therapy and family-focused therapy lengthen time to relapse when added to medication (Frank et al., 2005; McIntyre et al., 2020). They complement, rather than replace, mood-stabilizing drugs.
Support Organizations
Organizations that provide information, treatment referral, and advocacy for bipolar disorder and related mood conditions.
Depression and Bipolar Support Alliance — peer support, education, and advocacy for people living with mood disorders. (United States)
Bipolar UK — a national charity offering peer support and information for people affected by bipolar disorder. (United Kingdom)
National Institute of Mental Health — authoritative public-health information on symptoms, causes, and treatment. (United States)
References
Bourne, C., Aydemir, O., Balanza-Martinez, V., Bora, E., Brissos, S., Cavanagh, J. T. O., Clark, L., Cubukcuoglu, Z., Dias, V. V., Dittmann, S., Ferrier, I. N., Fleck, D. E., Frangou, S., Gallagher, P., Jones, L., Kieseppa, T., Martinez-Aran, A., Melle, I., Moore, P. B., ... Goodwin, G. M. (2013). Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: An individual patient data meta-analysis. Acta Psychiatrica Scandinavica, 128(3), 149-162. https://doi.org/10.1111/acps.12133
Craddock, N., & Sklar, P. (2013). Genetics of bipolar disorder. The Lancet, 381(9878), 1654-1662. https://doi.org/10.1016/S0140-6736(13)60855-7
Frank, E., Kupfer, D. J., Thase, M. E., Mallinger, A. G., Swartz, H. A., Fagiolini, A. M., Grochocinski, V., Houck, P., Scott, J., Thompson, W., & Monk, T. (2005). Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Archives of General Psychiatry, 62(9), 996-1004. https://doi.org/10.1001/archpsyc.62.9.996
Geddes, J. R., & Miklowitz, D. J. (2013). Treatment of bipolar disorder. The Lancet, 381(9878), 1672-1682. https://doi.org/10.1016/S0140-6736(13)60857-0
Goodwin, F. K., & Jamison, K. R. (2007). Manic-depressive illness: Bipolar disorders and recurrent depression (2nd ed.). Oxford University Press.
Grande, I., Berk, M., Birmaher, B., & Vieta, E. (2016). Bipolar disorder. The Lancet, 387(10027), 1561-1572. https://doi.org/10.1016/S0140-6736(15)00241-X
Harrison, P. J., Geddes, J. R., & Tunbridge, E. M. (2018). The emerging neurobiology of bipolar disorder. Trends in Neurosciences, 41(1), 18-30. https://doi.org/10.1016/j.tins.2017.10.006
Martinez-Aran, A., Vieta, E., Reinares, M., Colom, F., Torrent, C., Sanchez-Moreno, J., Benabarre, A., Goikolea, J. M., Comes, M., & Salamero, M. (2004). Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. American Journal of Psychiatry, 161(2), 262-270. https://doi.org/10.1176/appi.ajp.161.2.262
Merikangas, K. R., Jin, R., He, J. P., Kessler, R. C., Lee, S., Sampson, N. A., Viana, M. C., Andrade, L. H., Hu, C., Karam, E. G., Ladea, M., Medina-Mora, M. E., Ono, Y., Posada-Villa, J., Sagar, R., Wells, J. E., & Zarkov, Z. (2011). Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative. Archives of General Psychiatry, 68(3), 241-251. https://doi.org/10.1001/archgenpsychiatry.2011.12
McIntyre, R. S., Berk, M., Brietzke, E., Goldstein, B. I., Lopez-Jaramillo, C., Kessing, L. V., Malhi, G. S., Nierenberg, A. A., Rosenblat, J. D., Majeed, A., Vieta, E., Vinberg, M., Young, A. H., & Mansur, R. B. (2020). Bipolar disorders. The Lancet, 396(10265), 1841-1856. https://doi.org/10.1016/S0140-6736(20)31544-0
Phillips, M. L., & Swartz, H. A. (2014). A critical appraisal of neuroimaging studies of bipolar disorder: Toward a new conceptualization of underlying neural circuitry and a road map for future research. American Journal of Psychiatry, 171(8), 829-843. https://doi.org/10.1176/appi.ajp.2014.13081008
Post, R. M. (1992). Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. American Journal of Psychiatry, 149(8), 999-1010. https://doi.org/10.1176/ajp.149.8.999
Vieta, E., Berk, M., Schulze, T. G., Carvalho, A. F., Suppes, T., Calabrese, J. R., Gao, K., Miskowiak, K. W., & Grande, I. (2018). Bipolar disorders. Nature Reviews Disease Primers, 4, 18008. https://doi.org/10.1038/nrdp.2018.8
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978). A rating scale for mania: Reliability, validity and sensitivity. The British Journal of Psychiatry, 133, 429-435. https://doi.org/10.1192/bjp.133.5.429